Original Moderna vax to be phased out for bivalent shot: Butler
The replacement booster offers slightly increased protection against the latest SARS-CoV-2 variants.
The original Moderna COVID-19 vaccine will soon be phased out and replaced with the company’s new bivalent vaccine following ATAGI advice, the Federal Government says.
The modified Spikevax, which was provisionally approved for use in adults by the TGA last month, targets both the ancestral strain of SARS-CoV-2 and the Omicron BA.1 subvariant.
